Examination of utility in patients of unresectable or recurrent gastric cancer treated with paclitaxel or nab-paclitaxel or paclitaxel+ ramucirumab in our hospital

Takayuki Kii, Kazuhide Higuchi, Ken Asaishi et al.|Annals of Oncology|2017

Cited by 1